The antigens that constitute the ABO blood group system are oligosaccharides. Their biosynthesis is regulated by genes coding for specific glycosyltransferases that add monosaccharides to precursors in a sequential fashion (Fig 1) . In this way the product of one transferase becomes the substrate of the next, and the loss of activity of one transferase leads to the disappearance of the antigen it would have formed and all subsequent antigens, which would have been synthesised with this structure or its derivatives, as acceptor substrates. This complicated interrelation leads to a differential expression of blood group antigens in people with different genotypes. The role of the ABO, Se, H, X, and Le gene loci and their glycosyltransferase products in determining these antigens has been reviewed in detail elsewhere. These antigens are not only found in blood cells but are expressed in most epithelia and body fluids. In (Galp1-4GIcNAc-R) core structures are expressed in the fetal colon and rectum, and that there is a gradual disappearance or appreciable reduction in expression of blood group antigens apart from Lewisa in the distal colon during fetal growth.69 10 In contrast, all type 1, and to a less extent some type 2, chain antigens are expressed in the proximal colon in adults.8 In carcinomas of the distal colon, the ABH, Leb, Lex, and Le' antigens'-' and extended,8'" polyfucosylated, 8' or sialylated7 11 derivatives of these antigens have been shown by immunochemical and immunohistological means to reappear or to be synthesised de novo in large amounts. This has made them suitable as tumour markers,' '6 as more than two thirds of all colonic carcinomas are located in the distal colon.
The purpose of the present work was to examine the enzyme and structural basis for the differential expression of blood group carbohydrate antigens in the proximal and distal normal colon and in colorectal carcinomas. The enzyme findings have been correlated with immunochemical characterisation and immunohistochemical localisation of blood group antigens in tissues ofthe same subjects by the use of monoclonal antibodies with established carbohydrate specificities.
We report that control of the expression of type 1 chain, ABH, and Leb structures in both normal and malignant colon is probably through a-2-L-fucosyltransferase, whereas type 2 chain structures are, in addition, subject to other regulatory mechanisms. When ct-2-, a-3-, and a-4-L-fucosyltransferase activities occur together in an enzyme source, the substrate N-acetyllactosamine functions as an acceptor for both the a-2-and the a-3-transferases, and lacto-N-biose I as an acceptor for both ct-2-and ct-4-transferases. Difucosyl products are seldom observed and the products of Whitney two tailed test) . at-4-L-fucosyltransferase was significantly lower than a-3-L-fucosyltransferase in tumour tissue (p<0-001). The activity was measured as pmol ["4C] fucose incorporated into N-acetyllactosamine (a-3-L-fucosyltransferase) and lacto-N-biose I (a-4-L-fucosyltransferase)/h/mg. all three acceptor substrates (Table I) . Le(a+b-) individuals are believed to have a low or absent expression of at-2-L-fucosyltransferase in mucin secreting tissue. We therefore compared a-2-Lfucosyltransferase activity in tumour tissue from Le(a-b+) subjects with that from Le(a+b-) subjects (Table I) . We found significantly lower activity in tumour tissues from Le(a+b-) subjects (n=5) when phenyl-3-D-galactoside and lacto-N-biose I were used as acceptor substrates. Lower activity was also observed with N-acetyllactosamine as substrate in tissues from Le(a+b-) subjects, but the difference was not significant. In Le(a+b-) subjects it was remarkable to find a significantly higher ca-2-Lfucosyltransferase activity in tumour tissue compared with normal tissue with all three acceptor substrates (Table I) .
ct-3-and at-4-L-fucosyltransferases No significant difference could be found between the activities in tumour tissue and normal tissue (Table II) . ct-3-L-fucosyltransferase was active in all samples examined, whereas a-4-Lfucosyltransferase activity was related to the Lewis type of the subject, being almost absent in Le(a-b-) subjects. In tumours, the a-3-Lfucosyltransferase was significantly higher than the ct-4-L-fucosyltransferase, whereas both showed almost equal activity in normal tissue. a-2-L-fucosyltransferases compete with both the at-3-and ct-4-L-fucosyltransferases for a mutual acceptor substrate (Fig 1) . To evaluate alterations in this competitive action we calculated the ratios between the enzyme activities in each subject (Fig 2) . The individual approach was necessary to eliminate interindividual variation. The ct-4-/ a-2-L-fucosyltransferase ratio measured for both enzymes with lacto-N-biose I from rectum compared with normal rectal tissue (Fig 2) . The at-3-/a-2-L-fucosyltransferase ratio measured for both enzymes with N-acetyllactosamine as substrate was also significantly lower (p<0O005) in rectal tumour tissue than in normal rectal tissue.
a-3-N-acetyl-D-galactosaminyltransferase
This transferase was assayed at pH 6, which is the pH optimum for the A' transferase.21 Activity was only found in blood group A subjects (Table  III) . The activity in tumour tissue was lower (though not significant) than the activity in normal tissue. The individual ratios between the A' transferase and the fucosyltransferases with which it competes for acceptor substrates were not significantly altered.
GLYCOSYLTRANSFERASE ACTIVITY THROUGHOUT THE NORMAL COLON
The activity of the a-2-L-fucosyltransferase was higher in biopsy tissue from the caecum than from all other parts of the normal colon (Fig 3A) . The high activity in caecum was more pronounced when lacto-N-biose I and phenyl-,3-Dgalactoside were used as acceptors than when Nacetyllactosamine was used. The a-3-, ct-4-, and A' transferases (data for the A' transferase are not shown) were similar in activity throughout the colon. Because of this the individual a-4/a-2 ratio, and to a lesser extent the individual t-3/a-2 ratio, were much lower in caecum than in the rest of the colon (Fig 2) . None of these regional (Table IV) . Normal colonic specimens from caecum were stained in Le(a-b +) subjects by all the antibodies examined that were against type 1 chain H, Lea, Leb, and A antigens, whereas type 2 chain specific antibodies against Lex, Ley, H, and A antigens reacted more weakly (Table IV) .
In Le(a+b-) subjects only the type 1 chain antiLea specific antibody showed strong staining in caecum (Table IV) . In carcinomas from the rectum, however, all the antibodies gave positive staining patterns in Le(a-b+) subjects, and, remarkably, all but anti-H type 1, also in Le(a+ b-) subjects (Table IV) .
Discussion
The major difference observed in glycosyltransferase activity between normal rectal mucosa and rectosigmoidal carcinomas was the significantly increased activity of the a-2-Lfucosyltransferases in carcinomas from both secretors and non-secretors. This is in agreement with a previous report29 showing that, in comparison with normal colonic mucosa, the activity of the a-2-L-fucosyltransferases, as measured with phenyl-,B-D-galactoside, was increased in colonic carcinomas of ABH secretors. The present study also showed that the ae-2-Lfucosyltransferases were significantly higher in normal caecum than in normal rectum from secretors. All other transferases studied were of the same magnitude throughout the colon. The biosynthesis of H, A and Leb blood group determinants from their common precursor largely depends on the activity of the a-2-Lfucosyltransferases (Fig 1) . These antigens could be shown in rectal carcinomas and in normal caecum of secretors, but not in normal rectum. Therefore, we suggest that the a-2-L-fucosyltransferases control the expression of these blood group antigens in both normal and malignant human colon.
Non-secretors differed from secretors in the way that the a-2-L-fucosyltransferase activity was low in all regions of the normal colon, including caecum. It was remarkable, however, that rectal carcinomas from non-secretors showed a significant increase in ct-2-L-fucosyltransferase activity with all three acceptor substrates, the main difference in enzyme activity between rectal carcinomas from secretors and nonsecretors being higher activity with phenyl-13-Dgalactoside and lacto-N-biose I in secretors. This interesting enzymatic finding in non-secretors was shown to lead to antigen synthesis, as Leb, A, and ALeb antigens started to appear in rectal carcinomas from these subjects.
In colon mucosa there seem to be two forms of the a-2-L-fucosyltransferase, one that is Se gene dependent and has a preference for type 1 chain acceptors, and one, the H gene dependent, that is expressed independently of the Se gene and has a low activity with both type 1 and 2 chain acceptors.303' In non-secretors no activity was present in caecum, and the activity observed in rectal carcinomas of non-secretors showed similar levels of activity with both N-acetyllactosamine and lacto-N-biose I as acceptor substrates. These data indicate that in nonsecretors the H gene dependent a-2-L-fucosyltransferase is increased in colorectal carcinomas.
In secretors the present data show higher levels of ae-2-L-fucosyltransferase activity in normal caecum than in other regions of the colon with both type 1 and type 2 chain oligosaccharides and with phenyl-f3-D-galactoside as acceptor.
Increased activity with these acceptors was also seen in rectosigmoidal carcinomas compared with normal tissue from the same region (Table  I) . Phenyl-,3-D-galactoside is an efficient acceptor for the ct-2-L-fucosyltransferases and clearly distinguishes between secretors and nonsecretors when used to assay material from submaxillary glands.33 The high activity reported in secretors with this acceptor and with lacto-Nbiose I, and the difference in activity between secretors and non-secretors in both carcinomas and normal caecum, indicate that in secretors it is the Se gene dependent transferase which is increased in caecum. In colorectal carcinomas from secretors an increase in activity of the Se gene dependent ct-2-L-fucosyltransferase or an increase in both this transferase and the H gene dependent transferase could explain the present findings.
The ct-2-L-fucosyltransferase competes with a-3-and a-4-L-fucosyltransferases for mutual acceptor substrates (Fig 1) . If the ct-2-L-fucosyltransferase acts first the H antigen and subsequently Ley and Leb antigens are formed, whereas ifthe et-3-and a-4-L-fucosyltransferases act first, Lex and Lea antigens are formed. The last two antigens are poor substrates for the ca-2-L-fucosyltransferase and cannot be fucosylated to form Ley and Leb antigens. To determine the prevailing pathway of type 1 and 2 chain biosynthesis (Fig 1) , the individual ratios between a-4-/ct-2-and a-3-/at-2-fucosyltransferases measured respectively with lacto-N-biose I and N-acetyllactosamine were calculated for each subject. Both Reduction of a-3-N-acetyl-D-galactosaminyltransferase activity has previously been shown in intestinal carcinoma tissue.34 A reduction of this enzyme does not, however, seem to be important in the large bowel, as the present data confirm that carcinomas from A individuals can synthesise blood group A antigens when the a-2-fucosyltransferase level is increased.
The results suggest that the critical event required for blood group H, Leb, A, and B antigen biosynthesis, in both normal mucosa from the caecum and rectal carcinomas, is the expression of a-2-L-fucosyltransferase activity. 
